Skip to main content
Top
Published in: Sports Medicine 9/2013

01-09-2013 | Review Article

Genes for Elite Power and Sprint Performance: ACTN3 Leads the Way

Authors: Nir Eynon, Erik D. Hanson, Alejandro Lucia, Peter J. Houweling, Fleur Garton, Kathryn N. North, David J. Bishop

Published in: Sports Medicine | Issue 9/2013

Login to get access

Abstract

The ability of skeletal muscles to produce force at a high velocity, which is crucial for success in power and sprint performance, is strongly influenced by genetics and without the appropriate genetic make-up, an individual reduces his/her chances of becoming an exceptional power or sprinter athlete. Several genetic variants (i.e. polymorphisms) have been associated with elite power and sprint performance in the last few years and the current paradigm is that elite performance is a polygenic trait, with minor contributions of each variant to the unique athletic phenotype. The purpose of this review is to summarize the specific knowledge in the field of genetics and elite power performance, and to provide some future directions for research in this field. Of the polymorphisms associated with elite power and sprint performance, the α-actinin-3 R577X polymorphism provides the most consistent results. ACTN3 is the only gene that shows a genotype and performance association across multiple cohorts of elite power athletes, and this association is strongly supported by mechanistic data from an Actn3 knockout mouse model. The angiotensin-1 converting enzyme insertion/deletion polymorphism (ACE I/D, registered single nucleotide polymorphism [rs]4646994), angiotensinogen (AGT Met235Thr rs699), skeletal adenosine monophosphate deaminase (AMPD1) Gln(Q)12Ter(X) [also termed C34T, rs17602729], interleukin-6 (IL-6 −174 G/C, rs1800795), endothelial nitric oxide synthase 3 (NOS3 −786 T/C, rs2070744; and Glu298Asp, rs1799983), peroxisome proliferator-activated receptor-α (PPARA Intron 7 G/C, rs4253778), and mitochondrial uncoupling protein 2 (UCP2 Ala55Val, rs660339) polymorphisms have also been associated with elite power performance, but the findings are less consistent. In general, research into the genetics of athletic performance is limited by a small sample size in individual studies and the heterogeneity of study samples, often including athletes from multiple-difference sporting disciplines. In the future, large, homogeneous, strictly defined elite power athlete cohorts need to be established though multinational collaboration, so that meaningful genome-wide association studies can be performed. Such an approach would provide unbiased identification of potential genes that influence elite athletic performance.
Literature
1.
go back to reference Macarthur DG, North KN. Genes and human elite athletic performance. Hum Genet. 2005;116(5):331–9.PubMedCrossRef Macarthur DG, North KN. Genes and human elite athletic performance. Hum Genet. 2005;116(5):331–9.PubMedCrossRef
2.
go back to reference Druzhevskaya AM, Ahmetov II, Astratenkova IV, et al. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol. 2008;103(6):631–4.PubMedCrossRef Druzhevskaya AM, Ahmetov II, Astratenkova IV, et al. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol. 2008;103(6):631–4.PubMedCrossRef
3.
go back to reference Eynon N, Ruiz JR, Oliveira J, et al. Genes and elite athletes: a roadmap for future research. J Physiol. 2011;589(13):3063–70.PubMedCrossRef Eynon N, Ruiz JR, Oliveira J, et al. Genes and elite athletes: a roadmap for future research. J Physiol. 2011;589(13):3063–70.PubMedCrossRef
4.
go back to reference Stubbe JH, Boomsma DI, Vink JM, et al. Genetic influences on exercise participation in 37,051 twin pairs from seven countries. PloS one. 2006;1:e22.PubMedCrossRef Stubbe JH, Boomsma DI, Vink JM, et al. Genetic influences on exercise participation in 37,051 twin pairs from seven countries. PloS one. 2006;1:e22.PubMedCrossRef
5.
go back to reference De Moor MH, Spector TD, Cherkas LF, et al. Genome-wide linkage scan for athlete status in 700 British female DZ twin pairs. Twin Res Hum Genet. 2007;10(6):812–20.PubMedCrossRef De Moor MH, Spector TD, Cherkas LF, et al. Genome-wide linkage scan for athlete status in 700 British female DZ twin pairs. Twin Res Hum Genet. 2007;10(6):812–20.PubMedCrossRef
6.
go back to reference Bouchard C, Sarzynski MA, Rice TK, et al. Genomic predictors of the maximal O uptake response to standardized exercise training programs. J Appl Physiol. 2011;110(5):1160–70.PubMedCrossRef Bouchard C, Sarzynski MA, Rice TK, et al. Genomic predictors of the maximal O uptake response to standardized exercise training programs. J Appl Physiol. 2011;110(5):1160–70.PubMedCrossRef
7.
go back to reference Peeters MW, Thomis MA, Beunen GP, et al. Genetics and sports: an overview of the pre-molecular biology era. Med Sport Sci. 2009;54:28–42.PubMedCrossRef Peeters MW, Thomis MA, Beunen GP, et al. Genetics and sports: an overview of the pre-molecular biology era. Med Sport Sci. 2009;54:28–42.PubMedCrossRef
8.
go back to reference Calvo M, Rodas G, Vallejo M, et al. Heritability of explosive power and anaerobic capacity in humans. Eur J Appl Physiol. 2002;86(3):218–25.PubMedCrossRef Calvo M, Rodas G, Vallejo M, et al. Heritability of explosive power and anaerobic capacity in humans. Eur J Appl Physiol. 2002;86(3):218–25.PubMedCrossRef
9.
go back to reference Hagberg JM, Rankinen T, Loos RJ, et al. Advances in exercise, fitness, and performance genomics in 2010. Med Sci Sports Exerc. 2011;43(5):743–52.PubMedCrossRef Hagberg JM, Rankinen T, Loos RJ, et al. Advances in exercise, fitness, and performance genomics in 2010. Med Sci Sports Exerc. 2011;43(5):743–52.PubMedCrossRef
10.
go back to reference Rankinen T, Roth SM, Bray MS, et al. Advances in exercise, fitness, and performance genomics. Med Sci Sports Exerc. 2010;42(5):835–46.PubMedCrossRef Rankinen T, Roth SM, Bray MS, et al. Advances in exercise, fitness, and performance genomics. Med Sci Sports Exerc. 2010;42(5):835–46.PubMedCrossRef
11.
go back to reference Roth SM, Rankinen T, Hagberg JM, et al. Advances in exercise, fitness, and performance genomics in 2011. Med Sci Sports Exerc. 2012;44(5):809–17.PubMedCrossRef Roth SM, Rankinen T, Hagberg JM, et al. Advances in exercise, fitness, and performance genomics in 2011. Med Sci Sports Exerc. 2012;44(5):809–17.PubMedCrossRef
12.
go back to reference Ahmetov II, Williams AG, Popov DV, et al. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet. 2009;126(6):751–61.PubMedCrossRef Ahmetov II, Williams AG, Popov DV, et al. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet. 2009;126(6):751–61.PubMedCrossRef
13.
go back to reference Ruiz JR, Gomez-Gallego F, Santiago C, et al. Is there an optimum endurance polygenic profile? J Physiol. 2009;587(Pt 7):1527–34.PubMedCrossRef Ruiz JR, Gomez-Gallego F, Santiago C, et al. Is there an optimum endurance polygenic profile? J Physiol. 2009;587(Pt 7):1527–34.PubMedCrossRef
14.
go back to reference Mole PA, Oscai LB, Holloszy JO. Adaptation of muscle to exercise: increase in levels of palmityl Coa synthetase, carnitine palmityltransferase, and palmityl Coa dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest. 1971;50(11):2323–30.PubMedCrossRef Mole PA, Oscai LB, Holloszy JO. Adaptation of muscle to exercise: increase in levels of palmityl Coa synthetase, carnitine palmityltransferase, and palmityl Coa dehydrogenase, and in the capacity to oxidize fatty acids. J Clin Invest. 1971;50(11):2323–30.PubMedCrossRef
15.
go back to reference Spencer MR, Gastin PB. Energy system contribution during 200- to 1500-m running in highly trained athletes. Med Sci Sports Exerc. 2001;33(1):157–62.PubMed Spencer MR, Gastin PB. Energy system contribution during 200- to 1500-m running in highly trained athletes. Med Sci Sports Exerc. 2001;33(1):157–62.PubMed
16.
go back to reference Ahmetov, II, Druzhevskaya AM, Lyubaeva EV, et al. The dependence of preferred competitive racing distance on muscle fibre type composition and ACTN3 genotype in speed skaters. Exp Physiol. 2011;96(12):1302–10 Ahmetov, II, Druzhevskaya AM, Lyubaeva EV, et al. The dependence of preferred competitive racing distance on muscle fibre type composition and ACTN3 genotype in speed skaters. Exp Physiol. 2011;96(12):1302–10
17.
go back to reference Van Damme R, Wilson RS, Vanhooydonck B, et al. Performance constraints in decathletes. Nature. 2002;415(6873):755–6.PubMedCrossRef Van Damme R, Wilson RS, Vanhooydonck B, et al. Performance constraints in decathletes. Nature. 2002;415(6873):755–6.PubMedCrossRef
18.
go back to reference Seeman E, Hopper JL, Young NR, et al. Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study. Am J Physiol. 1996;270(2 Pt 1):E320–7.PubMed Seeman E, Hopper JL, Young NR, et al. Do genetic factors explain associations between muscle strength, lean mass, and bone density? A twin study. Am J Physiol. 1996;270(2 Pt 1):E320–7.PubMed
19.
go back to reference Thomis MA, Beunen GP, Maes HH, et al. Strength training: importance of genetic factors. Med Sci Sports Exerc. 1998;30(5):724–31.PubMedCrossRef Thomis MA, Beunen GP, Maes HH, et al. Strength training: importance of genetic factors. Med Sci Sports Exerc. 1998;30(5):724–31.PubMedCrossRef
20.
go back to reference Thomis MA, Beunen GP, Van Leemputte M, et al. Inheritance of static and dynamic arm strength and some of its determinants. Acta Physiol Scand. 1998;163(1):59–71.PubMedCrossRef Thomis MA, Beunen GP, Van Leemputte M, et al. Inheritance of static and dynamic arm strength and some of its determinants. Acta Physiol Scand. 1998;163(1):59–71.PubMedCrossRef
21.
go back to reference MacArthur DG, North KN. A gene for speed? The evolution and function of alpha-actinin-3. Bioessays. 2004;26(7):786–95.PubMedCrossRef MacArthur DG, North KN. A gene for speed? The evolution and function of alpha-actinin-3. Bioessays. 2004;26(7):786–95.PubMedCrossRef
22.
go back to reference Mills M, Yang N, Weinberger R, et al. Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet. 2001;10(13):1335–46.PubMedCrossRef Mills M, Yang N, Weinberger R, et al. Differential expression of the actin-binding proteins, alpha-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum Mol Genet. 2001;10(13):1335–46.PubMedCrossRef
23.
go back to reference North KN, Yang N, Wattanasirichaigoon D, et al. A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat Genet. 1999;21(4):353–4.PubMedCrossRef North KN, Yang N, Wattanasirichaigoon D, et al. A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat Genet. 1999;21(4):353–4.PubMedCrossRef
24.
go back to reference Yang N, MacArthur DG, Gulbin JP, et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet. 2003;73(3):627–31.PubMedCrossRef Yang N, MacArthur DG, Gulbin JP, et al. ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet. 2003;73(3):627–31.PubMedCrossRef
25.
go back to reference Eynon N, Duarte JA, Oliveira J, et al. ACTN3 R577X polymorphism and Israeli top-level athletes. Int J Sports Med. 2009;30(9):695–8.PubMedCrossRef Eynon N, Duarte JA, Oliveira J, et al. ACTN3 R577X polymorphism and Israeli top-level athletes. Int J Sports Med. 2009;30(9):695–8.PubMedCrossRef
26.
go back to reference Niemi AK, Majamaa K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet. 2005;13(8):965–9.PubMedCrossRef Niemi AK, Majamaa K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet. 2005;13(8):965–9.PubMedCrossRef
27.
go back to reference Doring FE, Onur S, Geisen U, et al. ACTN3 R577X and other polymorphisms are not associated with elite endurance athlete status in the Genathlete study. J Sports Sci. 2010;28(12):1355–9.PubMedCrossRef Doring FE, Onur S, Geisen U, et al. ACTN3 R577X and other polymorphisms are not associated with elite endurance athlete status in the Genathlete study. J Sports Sci. 2010;28(12):1355–9.PubMedCrossRef
28.
go back to reference Muniesa CA, Gonzalez-Freire M, Santiago C, et al. World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med. 2010;44(12):898–901.PubMedCrossRef Muniesa CA, Gonzalez-Freire M, Santiago C, et al. World-class performance in lightweight rowing: is it genetically influenced? A comparison with cyclists, runners and non-athletes. Br J Sports Med. 2010;44(12):898–901.PubMedCrossRef
29.
go back to reference Saunders CJ, September AV, Xenophontos SL, et al. No association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman Triathlons. Ann Hum Genet. 2007;71(Pt 6):777–81.PubMedCrossRef Saunders CJ, September AV, Xenophontos SL, et al. No association of the ACTN3 gene R577X polymorphism with endurance performance in Ironman Triathlons. Ann Hum Genet. 2007;71(Pt 6):777–81.PubMedCrossRef
30.
go back to reference Scott RA, Irving R, Irwin L, et al. ACTN3 and ACE genotypes in elite Jamaican and US sprinters. Med Sci Sports Exerc. 2010;42(1):107–12.PubMedCrossRef Scott RA, Irving R, Irwin L, et al. ACTN3 and ACE genotypes in elite Jamaican and US sprinters. Med Sci Sports Exerc. 2010;42(1):107–12.PubMedCrossRef
31.
go back to reference Yang N, MacArthur DG, Wolde B, et al. The ACTN3 R577X polymorphism in East and West African athletes. Med Sci Sports Exerc. 2007;39(11):1985–8.PubMedCrossRef Yang N, MacArthur DG, Wolde B, et al. The ACTN3 R577X polymorphism in East and West African athletes. Med Sci Sports Exerc. 2007;39(11):1985–8.PubMedCrossRef
32.
go back to reference Ruiz JR, Fernández del Valle M, Verde Z, et al. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scand J Med Sci Sports. 2011;21(6):e34–41.PubMedCrossRef Ruiz JR, Fernández del Valle M, Verde Z, et al. ACTN3 R577X polymorphism does not influence explosive leg muscle power in elite volleyball players. Scand J Med Sci Sports. 2011;21(6):e34–41.PubMedCrossRef
33.
go back to reference Papadimitriou ID, Papadopoulos C, Kouvatsi A, et al. The ACTN3 gene in elite Greek track and field athletes. Int J Sports Med. 2008;29(4):352–5.PubMedCrossRef Papadimitriou ID, Papadopoulos C, Kouvatsi A, et al. The ACTN3 gene in elite Greek track and field athletes. Int J Sports Med. 2008;29(4):352–5.PubMedCrossRef
34.
go back to reference Gineviciene V, Pranculis A, Jakaitiene A, et al. Genetic variation of the human ACE and ACTN3 genes and their association with functional muscle properties in Lithuanian elite athletes. Medicina. 2011;47(5):284–90.PubMed Gineviciene V, Pranculis A, Jakaitiene A, et al. Genetic variation of the human ACE and ACTN3 genes and their association with functional muscle properties in Lithuanian elite athletes. Medicina. 2011;47(5):284–90.PubMed
35.
go back to reference Roth SM, Walsh S, Liu D, et al. The ACTN3 R577X nonsense allele is under-represented in elite-level strength athletes. Eur J Hum Genet. 2008;16(3):391–4.PubMedCrossRef Roth SM, Walsh S, Liu D, et al. The ACTN3 R577X nonsense allele is under-represented in elite-level strength athletes. Eur J Hum Genet. 2008;16(3):391–4.PubMedCrossRef
36.
go back to reference Eynon N, Ruiz JR, Femia P, et al. The ACTN3 R577X polymorphism across three groups of elite male European athletes. PloS one. 2012;7(8):e43132.PubMedCrossRef Eynon N, Ruiz JR, Femia P, et al. The ACTN3 R577X polymorphism across three groups of elite male European athletes. PloS one. 2012;7(8):e43132.PubMedCrossRef
37.
go back to reference Chiu LL, Wu YF, Tang MT, et al. ACTN3 genotype and swimming performance in Taiwan. Int J Sports Med. 2011;32(6):476–80.PubMedCrossRef Chiu LL, Wu YF, Tang MT, et al. ACTN3 genotype and swimming performance in Taiwan. Int J Sports Med. 2011;32(6):476–80.PubMedCrossRef
38.
go back to reference Eynon N, Alves AJ, Meckel Y, et al. Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance? Metabolism. 2010;59(6):861–5.PubMedCrossRef Eynon N, Alves AJ, Meckel Y, et al. Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance? Metabolism. 2010;59(6):861–5.PubMedCrossRef
39.
go back to reference Eynon N, Alves AJ, Yamin C, et al. Is there an ACE ID—ACTN3 R577X polymorphisms interaction that influences sprint performance? Int J Sports Med. 2009;30(12):888–91.PubMedCrossRef Eynon N, Alves AJ, Yamin C, et al. Is there an ACE ID—ACTN3 R577X polymorphisms interaction that influences sprint performance? Int J Sports Med. 2009;30(12):888–91.PubMedCrossRef
40.
go back to reference Ruiz JR, Arteta D, Buxens A, et al. Can we identify a power-oriented polygenic profile? J Appl Physiol. 2010;108(3):561–6.PubMedCrossRef Ruiz JR, Arteta D, Buxens A, et al. Can we identify a power-oriented polygenic profile? J Appl Physiol. 2010;108(3):561–6.PubMedCrossRef
41.
go back to reference MacArthur DG, Seto JT, Raftery JM, et al. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat Genet. 2007;39(10):1261–5.PubMedCrossRef MacArthur DG, Seto JT, Raftery JM, et al. Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans. Nat Genet. 2007;39(10):1261–5.PubMedCrossRef
42.
go back to reference MacArthur DG, Seto JT, Chan S, et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet. 2008;17(8):1076–86.PubMedCrossRef MacArthur DG, Seto JT, Chan S, et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet. 2008;17(8):1076–86.PubMedCrossRef
43.
go back to reference Chan S, Seto JT, MacArthur DG, et al. A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse. Am J Physiol Cell Physiol. 2008;295(4):C897–904.PubMedCrossRef Chan S, Seto JT, MacArthur DG, et al. A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse. Am J Physiol Cell Physiol. 2008;295(4):C897–904.PubMedCrossRef
44.
go back to reference Berman Y, North KN. A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism. Physiology. 2010;25(4):250–9.PubMedCrossRef Berman Y, North KN. A gene for speed: the emerging role of alpha-actinin-3 in muscle metabolism. Physiology. 2010;25(4):250–9.PubMedCrossRef
45.
go back to reference Vincent B, De Bock K, Ramaekers M, et al. ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics. 2007;32(1):58–63.PubMedCrossRef Vincent B, De Bock K, Ramaekers M, et al. ACTN3 (R577X) genotype is associated with fiber type distribution. Physiol Genomics. 2007;32(1):58–63.PubMedCrossRef
46.
go back to reference Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–6.PubMedCrossRef Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343–6.PubMedCrossRef
47.
go back to reference Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995;92(6):1387–8.PubMedCrossRef Danser AH, Schalekamp MA, Bax WA, et al. Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation. 1995;92(6):1387–8.PubMedCrossRef
48.
go back to reference Myerson S, Hemingway H, Budget R, et al. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol. 1999;87(4):1313–6.PubMed Myerson S, Hemingway H, Budget R, et al. Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol. 1999;87(4):1313–6.PubMed
49.
go back to reference Costa AM, Silva AJ, Garrido ND, et al. Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol. 2009;106(6):785–90.PubMedCrossRef Costa AM, Silva AJ, Garrido ND, et al. Association between ACE D allele and elite short distance swimming. Eur J Appl Physiol. 2009;106(6):785–90.PubMedCrossRef
50.
go back to reference Juffer P, Furrer R, Gonzalez-Freire M, et al. Genotype distributions in top-level soccer players: a role for ACE? Int J Sports Med. 2009;30(5):387–92.PubMedCrossRef Juffer P, Furrer R, Gonzalez-Freire M, et al. Genotype distributions in top-level soccer players: a role for ACE? Int J Sports Med. 2009;30(5):387–92.PubMedCrossRef
51.
go back to reference Nazarov IB, Woods DR, Montgomery HE, et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet. 2001;9(10):797–801.PubMedCrossRef Nazarov IB, Woods DR, Montgomery HE, et al. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur J Hum Genet. 2001;9(10):797–801.PubMedCrossRef
52.
go back to reference Woods D, Hickman M, Jamshidi Y, et al. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet. 2001;108(3):230–2.PubMedCrossRef Woods D, Hickman M, Jamshidi Y, et al. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum Genet. 2001;108(3):230–2.PubMedCrossRef
53.
go back to reference Papadimitriou ID, Papadopoulos C, Kouvatsi A, et al. The ACE I/D polymorphism in elite Greek track and field athletes. J Sports Med Phys Fitness. 2009;49(4):459–63.PubMed Papadimitriou ID, Papadopoulos C, Kouvatsi A, et al. The ACE I/D polymorphism in elite Greek track and field athletes. J Sports Med Phys Fitness. 2009;49(4):459–63.PubMed
54.
go back to reference Sessa F, Chetta M, Petito A, et al. Gene polymorphisms and sport attitude in Italian athletes. Genet Test Mol Biomarkers. 2011;15(4):285–90.PubMedCrossRef Sessa F, Chetta M, Petito A, et al. Gene polymorphisms and sport attitude in Italian athletes. Genet Test Mol Biomarkers. 2011;15(4):285–90.PubMedCrossRef
55.
go back to reference Amir O, Amir R, Yamin C, et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol. 2007;92(5):881–6.PubMedCrossRef Amir O, Amir R, Yamin C, et al. The ACE deletion allele is associated with Israeli elite endurance athletes. Exp Physiol. 2007;92(5):881–6.PubMedCrossRef
56.
go back to reference Kim CH, Cho JY, Jeon JY, et al. ACE DD genotype is unfavorable to Korean short-term muscle power athletes. Int J Sports Med. 2010;31(1):65–71.PubMedCrossRef Kim CH, Cho JY, Jeon JY, et al. ACE DD genotype is unfavorable to Korean short-term muscle power athletes. Int J Sports Med. 2010;31(1):65–71.PubMedCrossRef
57.
go back to reference Zoossmann-Diskin A. The association of the ACE gene and elite athletic performance in Israel may be an artifact. Exp Physiol. 2008;93(11):1220 (author reply 1). Zoossmann-Diskin A. The association of the ACE gene and elite athletic performance in Israel may be an artifact. Exp Physiol. 2008;93(11):1220 (author reply 1).
58.
go back to reference Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation. 1997;96(3):741–7.PubMedCrossRef Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation. 1997;96(3):741–7.PubMedCrossRef
59.
go back to reference Sadoshima J, Xu Y, Slayter HS, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75(5):977–84.PubMedCrossRef Sadoshima J, Xu Y, Slayter HS, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75(5):977–84.PubMedCrossRef
60.
go back to reference Silva GJ, Moreira ED, Pereira AC, et al. ACE gene dosage modulates pressure-induced cardiac hypertrophy in mice and men. Physiol Genomics. 2006;27(3):237–44.PubMedCrossRef Silva GJ, Moreira ED, Pereira AC, et al. ACE gene dosage modulates pressure-induced cardiac hypertrophy in mice and men. Physiol Genomics. 2006;27(3):237–44.PubMedCrossRef
61.
go back to reference Berk BC, Vekshtein V, Gordon HM, et al. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13(4):305–14.PubMedCrossRef Berk BC, Vekshtein V, Gordon HM, et al. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension. 1989;13(4):305–14.PubMedCrossRef
62.
go back to reference Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62(4):749–56.PubMedCrossRef Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62(4):749–56.PubMedCrossRef
63.
go back to reference Gordon SE, Davis BS, Carlson CJ, et al. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab. 2001;280(1):E150–9.PubMed Gordon SE, Davis BS, Carlson CJ, et al. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab. 2001;280(1):E150–9.PubMed
64.
go back to reference Westerkamp CM, Gordon SE. Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2005;289(4):R1223–31.PubMedCrossRef Westerkamp CM, Gordon SE. Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2005;289(4):R1223–31.PubMedCrossRef
65.
go back to reference Charbonneau DE, Hanson ED, Ludlow AT, et al. ACE genotype and the muscle hypertrophic and strength responses to strength training. Med Sci Sports Exerc. 2008;40(4):677–83.PubMedCrossRef Charbonneau DE, Hanson ED, Ludlow AT, et al. ACE genotype and the muscle hypertrophic and strength responses to strength training. Med Sci Sports Exerc. 2008;40(4):677–83.PubMedCrossRef
66.
go back to reference Folland J, Leach B, Little T, et al. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol. 2000;85(5):575–9.PubMedCrossRef Folland J, Leach B, Little T, et al. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol. 2000;85(5):575–9.PubMedCrossRef
67.
go back to reference Zhang B, Tanaka H, Shono N, et al. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet. 2003;63(2):139–44.PubMedCrossRef Zhang B, Tanaka H, Shono N, et al. The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet. 2003;63(2):139–44.PubMedCrossRef
68.
go back to reference Zhang B, Shono N, Fan P, et al. Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout mice. Hypertens Res. 2005;28(8):681–8.PubMedCrossRef Zhang B, Shono N, Fan P, et al. Histochemical characteristics of soleus muscle in angiotensin-converting enzyme gene knockout mice. Hypertens Res. 2005;28(8):681–8.PubMedCrossRef
69.
go back to reference Bae JS, Kang BY, Lee KO, et al. Genetic variation in the renin–angiotensin system and response to endurance training. Med Princ Pract. 2007;16(2):142–6.PubMedCrossRef Bae JS, Kang BY, Lee KO, et al. Genetic variation in the renin–angiotensin system and response to endurance training. Med Princ Pract. 2007;16(2):142–6.PubMedCrossRef
70.
go back to reference Karjalainen J, Kujala UM, Stolt A, et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol. 1999;34(2):494–9.PubMedCrossRef Karjalainen J, Kujala UM, Stolt A, et al. Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. J Am Coll Cardiol. 1999;34(2):494–9.PubMedCrossRef
71.
go back to reference Gomez-Gallego F, Santiago C, Gonzalez-Freire M, et al. The C allele of the AGT Met235Thr polymorphism is associated with power sports performance. Appl Physiol Nutr Metab. 2009;34(6):1108–11.PubMedCrossRef Gomez-Gallego F, Santiago C, Gonzalez-Freire M, et al. The C allele of the AGT Met235Thr polymorphism is associated with power sports performance. Appl Physiol Nutr Metab. 2009;34(6):1108–11.PubMedCrossRef
72.
go back to reference Norman B, Sabina RL, Jansson E. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. J Appl Physiol. 2001;91(1):258–64.PubMed Norman B, Sabina RL, Jansson E. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. J Appl Physiol. 2001;91(1):258–64.PubMed
73.
go back to reference Rubio JC, Martin MA, Rabadan M, et al. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance? J Appl Physiol. 2005;98(6):2108–12.PubMedCrossRef Rubio JC, Martin MA, Rabadan M, et al. Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance? J Appl Physiol. 2005;98(6):2108–12.PubMedCrossRef
74.
go back to reference Morisaki T, Gross M, Morisaki H, et al. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA. 1992;89(14):6457–61.PubMedCrossRef Morisaki T, Gross M, Morisaki H, et al. Molecular basis of AMP deaminase deficiency in skeletal muscle. Proc Natl Acad Sci USA. 1992;89(14):6457–61.PubMedCrossRef
75.
go back to reference Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle Nerve. 1995;18(2):239–41.PubMedCrossRef Norman B, Glenmark B, Jansson E. Muscle AMP deaminase deficiency in 2% of a healthy population. Muscle Nerve. 1995;18(2):239–41.PubMedCrossRef
76.
go back to reference Norman B, Mahnke-Zizelman DK, Vallis A, et al. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol. 1998;85(4):1273–8.PubMed Norman B, Mahnke-Zizelman DK, Vallis A, et al. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. J Appl Physiol. 1998;85(4):1273–8.PubMed
77.
go back to reference Lucia A, Martin MA, Esteve-Lanao J, et al. C34T mutation of the AMPD1 gene in an elite white runner. Br J Sports Med. 2006;40(3):e7.PubMedCrossRef Lucia A, Martin MA, Esteve-Lanao J, et al. C34T mutation of the AMPD1 gene in an elite white runner. Br J Sports Med. 2006;40(3):e7.PubMedCrossRef
78.
go back to reference Fischer H, Esbjornsson M, Sabina RL, et al. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J Appl Physiol. 2007;103(1):315–22.PubMedCrossRef Fischer H, Esbjornsson M, Sabina RL, et al. AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects. J Appl Physiol. 2007;103(1):315–22.PubMedCrossRef
79.
go back to reference Cieszczyk P, Ostanek M, Leonska-Duniec A, et al. Distribution of the AMPD1 C34T polymorphism in Polish power-oriented athletes. J Sports Sci. 2012;30(1):31–5.PubMedCrossRef Cieszczyk P, Ostanek M, Leonska-Duniec A, et al. Distribution of the AMPD1 C34T polymorphism in Polish power-oriented athletes. J Sports Sci. 2012;30(1):31–5.PubMedCrossRef
80.
go back to reference Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98(4):1154–62.PubMedCrossRef Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98(4):1154–62.PubMedCrossRef
81.
go back to reference Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102(7):1369–76.PubMedCrossRef Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102(7):1369–76.PubMedCrossRef
82.
go back to reference Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275(24):18138–44.PubMedCrossRef Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem. 2000;275(24):18138–44.PubMedCrossRef
83.
go back to reference Bennermo M, Held C, Stemme S, et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem. 2004;50(11):2136–40.PubMedCrossRef Bennermo M, Held C, Stemme S, et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem. 2004;50(11):2136–40.PubMedCrossRef
84.
go back to reference Yamin C, Duarte JA, Oliveira JM, et al. IL6 (−174) and TNFA (−308) promoter polymorphisms are associated with systemic creatine kinase response to eccentric exercise. Eur J Appl Physiol. 2008;104(3):579–86.PubMedCrossRef Yamin C, Duarte JA, Oliveira JM, et al. IL6 (−174) and TNFA (−308) promoter polymorphisms are associated with systemic creatine kinase response to eccentric exercise. Eur J Appl Physiol. 2008;104(3):579–86.PubMedCrossRef
85.
go back to reference Ruiz JR, Buxens A, Artieda M, et al. The −174 G/C polymorphism of the IL6 gene is associated with elite power performance. J Sci Med Sport. 2010;13(5):549–53.PubMedCrossRef Ruiz JR, Buxens A, Artieda M, et al. The −174 G/C polymorphism of the IL6 gene is associated with elite power performance. J Sci Med Sport. 2010;13(5):549–53.PubMedCrossRef
86.
go back to reference Eynon N, Ruiz JR, Meckel Y, et al. Is the −174 C/G polymorphism of the IL6 gene associated with elite power performance? A replication study with two different Caucasian cohorts. Exp Physiol. 2011;96(2):156–62.PubMed Eynon N, Ruiz JR, Meckel Y, et al. Is the −174 C/G polymorphism of the IL6 gene associated with elite power performance? A replication study with two different Caucasian cohorts. Exp Physiol. 2011;96(2):156–62.PubMed
87.
go back to reference Cooke JP, Rossitch E Jr, Andon NA, et al. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88(5):1663–71.PubMedCrossRef Cooke JP, Rossitch E Jr, Andon NA, et al. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest. 1991;88(5):1663–71.PubMedCrossRef
88.
go back to reference Quyyumi AA, Dakak N, Andrews NP, et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995;92(3):320–6.PubMedCrossRef Quyyumi AA, Dakak N, Andrews NP, et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation. 1995;92(3):320–6.PubMedCrossRef
90.
go back to reference Hickner RC, Fisher JS, Ehsani AA, et al. Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans. Am J Physiol. 1997;273(1 Pt 2):H405–10.PubMed Hickner RC, Fisher JS, Ehsani AA, et al. Role of nitric oxide in skeletal muscle blood flow at rest and during dynamic exercise in humans. Am J Physiol. 1997;273(1 Pt 2):H405–10.PubMed
91.
go back to reference McConell GK, Kingwell BA. Does nitric oxide regulate skeletal muscle glucose uptake during exercise? Exerc Sport Sci Rev. 2006;34(1):36–41.PubMedCrossRef McConell GK, Kingwell BA. Does nitric oxide regulate skeletal muscle glucose uptake during exercise? Exerc Sport Sci Rev. 2006;34(1):36–41.PubMedCrossRef
92.
go back to reference Nakayama M, Yasue H, Yoshimura M, et al. T-786–>C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99(22):2864–70.PubMedCrossRef Nakayama M, Yasue H, Yoshimura M, et al. T-786–>C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99(22):2864–70.PubMedCrossRef
93.
go back to reference Wang XL, Sim AS, Wang MX, et al. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000;471(1):45–50.PubMedCrossRef Wang XL, Sim AS, Wang MX, et al. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000;471(1):45–50.PubMedCrossRef
94.
go back to reference Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998;103(1):65–9.PubMedCrossRef Yoshimura M, Yasue H, Nakayama M, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998;103(1):65–9.PubMedCrossRef
95.
go back to reference Hand BD, McCole SD, Brown MD, et al. NOS3 gene polymorphisms and exercise hemodynamics in postmenopausal women. Int J Sports Med. 2006;27(12):951–8.PubMedCrossRef Hand BD, McCole SD, Brown MD, et al. NOS3 gene polymorphisms and exercise hemodynamics in postmenopausal women. Int J Sports Med. 2006;27(12):951–8.PubMedCrossRef
96.
go back to reference Rankinen T, Rice T, Perusse L, et al. NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension. 2000;36(5):885–9.PubMedCrossRef Rankinen T, Rice T, Perusse L, et al. NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension. 2000;36(5):885–9.PubMedCrossRef
97.
go back to reference Gomez-Gallego F, Ruiz JR, Buxens A, et al. The −786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports. Eur J Appl Physiol. 2009;107(5):565–9.PubMedCrossRef Gomez-Gallego F, Ruiz JR, Buxens A, et al. The −786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports. Eur J Appl Physiol. 2009;107(5):565–9.PubMedCrossRef
98.
go back to reference Kawada S, Ishii N. Skeletal muscle hypertrophy after chronic restriction of venous blood flow in rats. Med Sci Sports Exerc. 2005;37(7):1144–50.PubMedCrossRef Kawada S, Ishii N. Skeletal muscle hypertrophy after chronic restriction of venous blood flow in rats. Med Sci Sports Exerc. 2005;37(7):1144–50.PubMedCrossRef
99.
go back to reference Smith LW, Smith JD, Criswell DS. Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload. J Appl Physiol. 2002;92(5):2005–11.PubMed Smith LW, Smith JD, Criswell DS. Involvement of nitric oxide synthase in skeletal muscle adaptation to chronic overload. J Appl Physiol. 2002;92(5):2005–11.PubMed
100.
go back to reference Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ. 2006;30(4):145–51.PubMedCrossRef Liang H, Ward WF. PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ. 2006;30(4):145–51.PubMedCrossRef
101.
go back to reference Jamshidi Y, Montgomery HE, Hense HW, et al. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation. 2002;105(8):950–5.PubMedCrossRef Jamshidi Y, Montgomery HE, Hense HW, et al. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation. 2002;105(8):950–5.PubMedCrossRef
102.
go back to reference Flavell DM, Jamshidi Y, Hawe E, et al. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation. 2002;105(12):1440–5.PubMedCrossRef Flavell DM, Jamshidi Y, Hawe E, et al. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation. 2002;105(12):1440–5.PubMedCrossRef
103.
go back to reference Ahmetov II, Mozhayskaya IA, Flavell DM, et al. PPARalpha gene variation and physical performance in Russian athletes. Eur J Appl Physiol. 2006;97(1):103–8.PubMedCrossRef Ahmetov II, Mozhayskaya IA, Flavell DM, et al. PPARalpha gene variation and physical performance in Russian athletes. Eur J Appl Physiol. 2006;97(1):103–8.PubMedCrossRef
104.
go back to reference Eynon N, Meckel Y, Sagiv M, et al. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Scand J Med Sci Sports. 2010;20(1):e145–50.PubMedCrossRef Eynon N, Meckel Y, Sagiv M, et al. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? Scand J Med Sci Sports. 2010;20(1):e145–50.PubMedCrossRef
105.
go back to reference Rance KA, Johnstone AM, Murison S, et al. Plasma leptin levels are related to body composition, sex, insulin levels and the A55V polymorphism of the UCP2 gene. Int J Obes (Lond). 2007;31(8):1311–8.CrossRef Rance KA, Johnstone AM, Murison S, et al. Plasma leptin levels are related to body composition, sex, insulin levels and the A55V polymorphism of the UCP2 gene. Int J Obes (Lond). 2007;31(8):1311–8.CrossRef
106.
go back to reference Oktavianthi S, Trimarsanto H, Febinia CA, et al. Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol. 2012;11(1):41.PubMedCrossRef Oktavianthi S, Trimarsanto H, Febinia CA, et al. Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol. 2012;11(1):41.PubMedCrossRef
107.
go back to reference Martinez-Hervas S, Mansego ML, de Marco G, et al. Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population. Eur J Clin Invest. 2012;42(2):171–8.PubMedCrossRef Martinez-Hervas S, Mansego ML, de Marco G, et al. Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population. Eur J Clin Invest. 2012;42(2):171–8.PubMedCrossRef
108.
go back to reference Moran CN, Yang N, Bailey ME, et al. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet. 2007;15(1):88–93.PubMedCrossRef Moran CN, Yang N, Bailey ME, et al. Association analysis of the ACTN3 R577X polymorphism and complex quantitative body composition and performance phenotypes in adolescent Greeks. Eur J Hum Genet. 2007;15(1):88–93.PubMedCrossRef
109.
go back to reference Williams AG, Folland JP. Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol. 2008;586(1):113–21.PubMedCrossRef Williams AG, Folland JP. Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol. 2008;586(1):113–21.PubMedCrossRef
110.
go back to reference Buxens A, Ruiz JR, Arteta D, et al. Can we predict top-level sports performance in power vs endurance events? A genetic approach. Scand J Med Sci Sports. 2011;21(4):570–9.PubMedCrossRef Buxens A, Ruiz JR, Arteta D, et al. Can we predict top-level sports performance in power vs endurance events? A genetic approach. Scand J Med Sci Sports. 2011;21(4):570–9.PubMedCrossRef
111.
go back to reference Clarkson PM, Devaney JM, Gordish-Dressman H, et al. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol. 2005;99(1):154–63.PubMedCrossRef Clarkson PM, Devaney JM, Gordish-Dressman H, et al. ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. J Appl Physiol. 2005;99(1):154–63.PubMedCrossRef
112.
go back to reference Pimenta EM, Coelho DB, Cruz IR, et al. The ACTN3 genotype in soccer players in response to acute eccentric training. Eur J Appl Physiol. 2012;112(4):1495–503.PubMedCrossRef Pimenta EM, Coelho DB, Cruz IR, et al. The ACTN3 genotype in soccer players in response to acute eccentric training. Eur J Appl Physiol. 2012;112(4):1495–503.PubMedCrossRef
113.
go back to reference Seto JT, Chan S, Turner N, et al. The effect of alpha-actinin-3 deficiency on muscle aging. Exp Gerontol. 2011;46(4):292–302.PubMedCrossRef Seto JT, Chan S, Turner N, et al. The effect of alpha-actinin-3 deficiency on muscle aging. Exp Gerontol. 2011;46(4):292–302.PubMedCrossRef
114.
go back to reference Alfred T, Ben-Shlomo Y, Cooper R, et al. ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies. Hum Mutat. 2011;32(9):1008–18. Alfred T, Ben-Shlomo Y, Cooper R, et al. ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies. Hum Mutat. 2011;32(9):1008–18.
115.
go back to reference Delmonico MJ, Zmuda JM, Taylor BC, et al. Association of the ACTN3 genotype and physical functioning with age in older adults. J Gerontol A Biol Sci Med Sci. 2008;63(11):1227–34.PubMedCrossRef Delmonico MJ, Zmuda JM, Taylor BC, et al. Association of the ACTN3 genotype and physical functioning with age in older adults. J Gerontol A Biol Sci Med Sci. 2008;63(11):1227–34.PubMedCrossRef
116.
go back to reference Garatachea N, Fiuza-Luces C, Torres-Luque G, et al. Single and combined influence of ACE and ACTN3 genotypes on muscle phenotypes in octogenarians. Eur J Appl Physiol. 2012;112(7):2409–20.PubMedCrossRef Garatachea N, Fiuza-Luces C, Torres-Luque G, et al. Single and combined influence of ACE and ACTN3 genotypes on muscle phenotypes in octogenarians. Eur J Appl Physiol. 2012;112(7):2409–20.PubMedCrossRef
117.
go back to reference Seto JT, Lek M, Quinlan KG, et al. Deficiency of alpha-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Hum Mol Genet. 2011;20(15):2914–27.PubMedCrossRef Seto JT, Lek M, Quinlan KG, et al. Deficiency of alpha-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Hum Mol Genet. 2011;20(15):2914–27.PubMedCrossRef
118.
go back to reference Clarkson PM, Hoffman EP, Zambraski E, et al. ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol. 2005;99(2):564–9.PubMedCrossRef Clarkson PM, Hoffman EP, Zambraski E, et al. ACTN3 and MLCK genotype associations with exertional muscle damage. J Appl Physiol. 2005;99(2):564–9.PubMedCrossRef
119.
go back to reference MacArthur DG, Balasubramanian S, Frankish A, et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012;335(6070):823–8.PubMedCrossRef MacArthur DG, Balasubramanian S, Frankish A, et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science. 2012;335(6070):823–8.PubMedCrossRef
120.
go back to reference Hong E, Park J. Sample size and statistical power calculations. Genomics Inform. 2012;10(2):117–22.PubMedCrossRef Hong E, Park J. Sample size and statistical power calculations. Genomics Inform. 2012;10(2):117–22.PubMedCrossRef
121.
go back to reference Santiago C, Gonzalez-Freire M, Serratosa L, et al. ACTN3 genotype in professional soccer players. Br J Sports Med. 2008;42(1):71–3.PubMedCrossRef Santiago C, Gonzalez-Freire M, Serratosa L, et al. ACTN3 genotype in professional soccer players. Br J Sports Med. 2008;42(1):71–3.PubMedCrossRef
Metadata
Title
Genes for Elite Power and Sprint Performance: ACTN3 Leads the Way
Authors
Nir Eynon
Erik D. Hanson
Alejandro Lucia
Peter J. Houweling
Fleur Garton
Kathryn N. North
David J. Bishop
Publication date
01-09-2013
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 9/2013
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-013-0059-4

Other articles of this Issue 9/2013

Sports Medicine 9/2013 Go to the issue